Evidence map›Paper›PMID 42603909›Full record

ArticleMolecular neurodegeneration advances2026

Proteomic analysis of human chronic traumatic encephalopathy brain implicates proteasome and ribosome dysfunction in disease severity.

Helen E Pennington, Dillon Shapiro, Jenny Empawi, Nurgul Aytan, Victor E Alvarez, Jessie Mez, Michael L Alosco, Xiaoling Zhang, Ann C McKee, Thor D Stein and 2 more

Abstract read
In one paragraph

Article in Molecular neurodegeneration advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Helen E Pennington *Bioinformatics Program, Boston University, Boston Massachusetts, USA.
Dillon Shapiro *Department of Neurology, Boston University Alzheimer's Disease Research Center and CTE Centers, Chobanian & Avedisian School of Medicine, Boston Unviersity, Boston Massachusetts, USA.
Jenny EmpawiDepartment of Neurology, Boston University Alzheimer's Disease Research Center and CTE Centers, Chobanian & Avedisian School of Medicine, Boston Unviersity, Boston Massachusetts, USA.
Nurgul AytanVA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston Massachusetts, USA.
Victor E AlvarezVA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston Massachusetts, USA.
Jessie MezDepartment of Neurology, Boston University Alzheimer's Disease Research Center and CTE Centers, Chobanian & Avedisian School of Medicine, Boston Unviersity, Boston Massachusetts, USA.
Michael L AloscoDepartment of Neurology, Boston University Alzheimer's Disease Research Center and CTE Centers, Chobanian & Avedisian School of Medicine, Boston Unviersity, Boston Massachusetts, USA.
Xiaoling ZhangDepartment of Neurology, Boston University Alzheimer's Disease Research Center and CTE Centers, Chobanian & Avedisian School of Medicine, Boston Unviersity, Boston Massachusetts, USA.
Ann C McKeeVA Bedford Healthcare System, Bedford Massachusetts, USA.
Thor D SteinVA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston Massachusetts, USA.
Jonathan D Cherry *VA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston Massachusetts, USA.
Adam Labadorf *Bioinformatics Program, Boston University, Boston Massachusetts, USA.ORCID https://orcid.org/0000-0002-0753-8992

Funding

Characterization of the spatial and temporal response to tau in chronic traumatic encephalopathyR01AG090553 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Jonathan D Cherry, Adam Thomas Labadorf · 2025 to 2026
$1.6M
Predoctoral Training in Bioinformatics and Computational BiologyT32GM150533 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GARY E. BENSON, Daniel Segre · 2023 to 2026
$1.3M
NIA NIH HHS R01 AG090553NIGMS NIH HHS T32 GM150533
6 · The paper itself

Abstract

Background: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that occurs in individuals with repeated head impacts (RHI) exposure, including contact sport athletes, military personnel, and domestic abuse victims. Despite growing recognition of CTE, the molecular mechanisms underlying the disease process remain poorly understood. This study aims to identify proteomic alterations associated with CTE pathology and clinical features to elucidate key biological pathways involved in disease pathogenesis. Methods: SomaScan 7 k high-throughput proteomics was performed on 204 dorsolateral prefrontal cortex samples from the Boston University CTE Center Brain Bank. We identified differentially expressed proteins associated with CTE, hyperphosphorylated tau (ptau) pathology, duration of contact sports play, dementia status, and Cognitive Difficulty Scale (CDS) scores. Results: Gene set enrichment analysis revealed that proteasome subunit proteins and related pathways were strongly associated with CTE severity and correlated with years of contact sports play. Reduction in ribosomal proteins and pathways was closely associated with ptau burden. Additionally, multiple models demonstrated significant alterations in MAPK-related cell signaling pathways. Conclusions: These findings advance our understanding of the postmortem brain CTE molecular profile and identify biological and molecular processes correlated with key pathological features of the disease. Validation of these results could inform the development of diagnostics and treatments for CTE. Supplementary Information: The online version contains supplementary material available at 10.1186/s44477-026-00045-w.

Indexed as

CTENeurodegenerationProteomicsRepetitive head impactsTauopathy

Identifiers

PMID42603909
PMCPMC13476330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.